Last €92.75 EUR
Change Today +4.19 / 4.73%
Volume 0.0
82P On Other Exchanges
As of 10:34 AM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

pacira pharmaceuticals inc (82P) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/28/15 - €94.22
52 Week Low
02/13/14 - €44.37
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for PACIRA PHARMACEUTICALS INC (82P)

pacira pharmaceuticals inc (82P) Related Bloomberg News

View More Bloomberg News

pacira pharmaceuticals inc (82P) Related Businessweek News

No Related Businessweek News Found

pacira pharmaceuticals inc (82P) Details

Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures pharmaceutical products primarily for use in hospitals and ambulatory surgery centers worldwide. It develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. The company commercializes EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic indicated for administration into the surgical site to produce postsurgical analgesia; and DepoCyt(e), a liposomal formulation of the chemotherapeutic agent cytarabine indicated for the intrathecal treatment of lymphomatous meningitis, a cancer of the immune system. Its product pipeline comprise EXPAREL that has completed Phase III clinical trials for postsurgical analgesia-nerve block administration; DepoNSAID, which is in preclinical trials for the relief of acute pain; and DepoMethotrexate, an oncology preclinical candidate, as well as Bupivacaine Liposome Injectable Suspension for veterinary postsurgical analgesia. Pacira Pharmaceuticals, Inc. has a development and commercialization agreement, and related supply agreement with Aratana Therapeutics, Inc. The company was formerly known as Pacira, Inc. and changed its name to Pacira Pharmaceuticals, Inc. in October 2010. Pacira Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.

308 Employees
Last Reported Date: 02/25/14
Founded in 2006

pacira pharmaceuticals inc (82P) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $916.2K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $468.4K
Chief Commercial Officer and Senior Vice Pres...
Total Annual Compensation: $458.9K
Chief Medical Officer
Total Annual Compensation: $367.6K
Principal Accounting Officer and Executive Di...
Total Annual Compensation: $288.4K
Compensation as of Fiscal Year 2013.

pacira pharmaceuticals inc (82P) Key Developments

Pacira Pharmaceuticals, Inc. - Analyst/Investor Day

To provide an overview of the company's future expansion plans for additional EXPAREL indications, as well as the leading DepoFoam-based product candidates

Pacira Pharmaceuticals, Inc. Provides Revenue Guidance for the Fourth Quarter and Full-Year of 2014

Pacira Pharmaceuticals, Inc. provided revenue guidance for the fourth quarter and full-year of 2014. For the fourth quarter, the company expects total revenues of $61.8 million in the fourth quarter of 2014, which represents an increase of 84% over $33.6 million in the fourth quarter of 2013. For the full year 2014, the company expects total revenues of $197.7 million in 2014, a 13% increase over $85.6 million in 2013.

Pacira Pharmaceuticals, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 08:30 AM

Pacira Pharmaceuticals, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 08:30 AM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Dave Stack, president, chief executive officer and chairman.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
82P:GR €92.75 EUR +4.19

82P Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Akorn Inc $43.08 USD +0.07
Cumberland Pharmaceuticals Inc $5.73 USD -0.03
Durect Corp $0.94 USD +0.0145
Halyard Health Inc $45.93 USD +0.095
Teleflex Inc $111.40 USD +0.46
View Industry Companies

Industry Analysis


Industry Average

Valuation 82P Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 21.5x
Price/Book 23.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 20.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PACIRA PHARMACEUTICALS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at